1-20 of 39
Lihong Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and effectiveness of brentuximab vedotin in Chinese adult patients with classical Hodgkin's lymphoma: Results from a multicenter, prospective, observational, real-world study

Free
Wei Li, Chuanxu Liu, Wenyang Huang, Ou Bai, Lihong Liu, Zengjun Li, Wei Xu, Wei Zhang, Liping Su, Kaiyang Ding, Luqun Wang, Guohui Cui, Hongmei Jing, Jianli Wang, Ziheng Guo, Weili Zhao, Huilai Zhang
Journal: Blood
Blood (2025) 146 (Supplement 1): 7135.
https://doi.org/10.1182/blood-2025-7135
Published: 2025
Journal Articles

Efficacy and safety of rocbrutinib, the fourth generation bruton's tyrosine kinase inhibitor, in patients with BTK inhibitor pre-treated relapsed or refractory Mantle Cell Lymphoma: Results from a Phase II rock-1 trial

Free
Yuqin Song, Qingqing Cai, Xiaoqiong Tang, Keshu Zhou, Lihong Liu, Zhigang Peng, Xiaojing Yan, Kaiyang Ding, Jianzhen Shen, Huijing Wu, Jie Cui, Hui Zhou, Jianqiu Wu, Hongmei Jing, Ming Jiang, Xiuhua Sun, Yu Yang, Kang Yu, Wei Yang, Zhifeng Li, Zhengming Jin, Shuhua Yi, Fei Li, Guowu Wu, Xiaolei Wei, Gaoxiang Wang, Yudan Wu, Ningjing Lin, Fenlai Tan, Yue Shen, Yejiang Lou, Xiang Xiao, Jun Zhu
Journal: Blood
Blood (2025) 146 (Supplement 1): 886.
https://doi.org/10.1182/blood-2025-886
Published: 2025
Journal Articles

A prospective, multicenter, real-world study of glofitamab in Chinese patients with relapsed or refractory large B-cell lymphoma

Free
Li Wang, Jiayin He, Zhihua Yao, Hongmei Jing, Songfu Jiang, Xia Zhao, Wenrong Huang, Hongbin Lu, Zhao Peiqi, Lihong Liu, Jianzhen Shen, Wei Li Zhao
Journal: Blood
Blood (2025) 146 (Supplement 1): 7252.
https://doi.org/10.1182/blood-2025-7252
Published: 2025
Journal Articles

Tucidinostat plus R-CHOP in untreated MYC/BCL2 double-expressor diffuse large B-cell lymphoma：topline efficacy and safety results from the randomized phase 3 DEB study

Free
Wei Li Zhao, Jun Zhu, Pengpeng Xu, Yuqin Song, Jianzhen Shen, Qingqing Cai, Hui Zhou, Liling Zhang, Ying Xiang, Xiuhua Sun, Wei Yang, Zhihua Yao, Hongmei Jing, Shujuan Wen, Jie Jin, Hongwei Xue, Hong Cen, Kaiyang Ding, Zhengming Jin, Lihong Liu, Xiaojing Xing, Lanfang Li, Ming Hou, Lin LIU, Mingzhi Zhang, Wenyu Li, Ou Bai, Ru Feng, Zunmin Zhu, Huijing Wu, Liping Su, Li Gao, Fei Li, Wenrong Huang, Peng Liu, Xiaojing Yan, Ying Zhao, Hang Su, Xielan Zhao, Rong FU, Hong Liu, Wenyu Shi
Journal: Blood
Blood (2025) 146 (Supplement 1): 475.
https://doi.org/10.1182/blood-2025-475
Published: 2025
Journal Articles

Results of a registrational Phase 2 study of lisaftoclax monotherapy for treatment of patients (pts) with Relapsed/Refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who had failed Bruton's tyrosine kinase inhibitors (BTKis)

Free
Keshu Zhou, Tingyu Wang, Ting Niu, Meifang Zheng, Jie Jin, Yang Liang, Rui Huang, Shuangnian Xu, Jianhua Qu, Guohui Cui, Fei Li, Yiming Luo, Ru Feng, Wenzheng Yu, Caixia Li, Zhiling Yan, Xin Zhou, Suijing Wu, Lihong Liu, Yinghua Geng, Jishi Wang, Sujun Gao, Jianfei Fu, Xiaoping Zhang, Chunyan Ji, Qianqian Xiang, Xiongpeng Zhu, Yajing Xu, Li'e Lin, Xiaoyu Zhu, Yuping Zhong, Hongling Peng, Ying Zhao, Hui Zeng, Zhao Wang, Rong Fu, Wenbin Qian, Yingmin Liang, Xiaobing Huang, Yajun Li, Min Yu, Zi Chen, Lei Wang, Lichuang Men, Zhiyan Liang, Shan Zeng, Baoer Lu, Yifan Zhai, Jianyong Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 88.
https://doi.org/10.1182/blood-2025-88
Published: 2025
Journal Articles

Enhanced efficacy and safety of optimized tandem CD19/CD20 CAR T-cell Therapy in refractory/relapsed B-cell lymphoma

Free
Jiaqi Guo, Ang Zhang, Weiwei Tian, Xiaoxi Zhou, Xiao Zhao, Yang Cao, Shaolong He, Jie Zhao, Lihong Liu, Lifang Huang, Yicheng Zhang, Bing Liu, Jia Wei
Journal: Blood
Blood (2025) 146 (Supplement 1): 2325.
https://doi.org/10.1182/blood-2025-2325
Published: 2025
Journal Articles

Efficacy and safety of mitoxantrone hydrochloride liposome in peripheral T-cell lymphoma: A multicenter, non-interventional, ambispective cohort real-world study

Free
Donglu Zhao, Huiqiang Huang, Zhiming Li, Lihong Liu, Quande Lin, Jun Fang, Kaiyang Ding, Jie Jin, Yanhong Tong, Dengju Li, Zengjun Li, Liping Su, Liang Wang, Wenbin Qian, Xiuhua Sun, Xiaobo Wang, Pengcheng He, Wei Yang, Jinhai Ren, Liling Zhang, Zunmin Zhu, Lugui Qiu, Dehui Zou, Wei LIU, Hui Zhou, Dongfeng Luo, Xiaojing Yan, Zhenqian Huang, Lintao Bi, Rong FU, Yunhong Huang, Aichun Liu, Xi Zhang, Yao Liu, Hao Zhang, Guangxun Gao, Liangquan Geng, Jingbo Wang, Jia Li, Yi Wang, Liqun Zou, Ming Jiang, Jian Ge, Xiu Li Sun, Yanli Yang, Hongmei Jing, Kai Hu, Zhimin Yan, Shuangnian Xu, Xiangxiang Zhou, Ganggang Wang, Zhilin Gao, Li Liang, Hongfeng Ge, Qingshan Li, Zhixue Zhang, Wuping Li, Xiaojing Xing, Fengzi Wang, Dongping Huang, Jun Qian, Hua Fan, Chanjuan Shen, Jun Ma
Journal: Blood
Blood (2025) 146 (Supplement 1): 1878.
https://doi.org/10.1182/blood-2025-1878
Published: 2025
Journal Articles

Efficacy and Safety of a New Regime Containing PD1 Antibody and Pegaspargase for Advanced-Stage or Relapsed/Refractory Natural Killer/T Cell Lymphoma

Free
Jie Chen, Linjun Zhao, Chongyang Wu, Haifeng Yu, Zhenling Li, Lihong Liu, Da Gao, Ying Sun, Xiaolei Wei, Yuanbin Wu, Yue Wang, Yuqin Song, Jun Zhu, Weiping Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 1686.
https://doi.org/10.1182/blood-2024-207412
Published: 2024
Journal Articles

Clinical Efficacy and Safety Evaluation of Isazomib Based Combination Regimen for Multiple Myeloma First-Line Therapy

Free
Yan Bai, Yuhuan Gao, Lihong Liu, Lanping Diao, Xiaolin Wu, Shaoning Yin, Huilai Zhang, Chen Huang
Journal: Blood
Blood (2024) 144 (Supplement 1): 7029.
https://doi.org/10.1182/blood-2024-205537
Published: 2024
Journal Articles

Tandem CD19/20 CAR-T Showed Durable Efficacy in Patients with Relapsed/Refractory B-Cell Lymphoma: Interim Results from a Multicenter Phase I/II Trial

Free
Jia Wei, Xiaoxi Zhou, Hui Luo, Yang Cao, Jiaqi Guo, Jie Zhao, Lifang Huang, Ang Zhang, Lihong Liu, Weiwei Tian, Yicheng Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 3132.
https://doi.org/10.1182/blood-2024-205207
Published: 2024
Journal Articles

In-Class Transition (iCT) of Proteasome Inhibitor-Based Therapy Prolongs Progression-Free Survival in High-Risk Myeloma Patients: A Real-World Chinese Cohort Study

Free
Rong Fu, Hong Yu, Aijun Liu, Rui Hou, Zunmin Zhu, Junling Zhuang, Li Bao, Zhenling Li, Lihong Liu, Luoming Hua, Yanping Ma, Da Gao, ARong Jin, Xiaohui Suo, Wei Yang, Yuansong Bai, Deqiang Zheng, Wenming Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 7846.
https://doi.org/10.1182/blood-2024-209471
Published: 2024
Journal Articles

Molecular Mechanistic Insights and Real-World Clinical Outcomes of Selinexor in Diffuse Large B-Cell Lymphoma

Free
Wenqi Zhang, Yuhuan Gao, Lanping Diao, Lihong Liu, Guangyu Ma, Guimin Zhao, Haisheng Liu, Huilai Zhang, Chen Huang
Journal: Blood
Blood (2024) 144 (Supplement 1): 6184.
https://doi.org/10.1182/blood-2024-203366
Published: 2024
Journal Articles

SG301, a Novel Anti-CD38 Monoclonal Antibody, in Patients with Relapsed/Refractory Multiple Myeloma: A First-in-Human, Multicentre, Phase 1 Trial

Free
Ying Tian, Keshu Zhou, Quande Lin, Wenbin Qian, Wei Yang, Li Bao, Guolin Yuan, Xiaojing Yan, Liangming Ma, Xin Zhou, Lihong Liu, Fangbing Zhu, Xuelan Zuo, Xin Du, Xu Ji, Xuzhao Zhang, Jing Shen, Hai Zhou, Na Li, Wenming Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 4746.
https://doi.org/10.1182/blood-2024-199381
Published: 2024
Journal Articles

Subgroup Analysis from a Phase 2, Single-Arm Trial of the Oral PI3Kδ Inhibitor Linperlisib in Patients with Relapsed or Refractory Follicular Lymphoma

Free
Tingyu Wang, Xiuhua Sun, Lihua Qiu, Hang Su, Junning Cao, Zhiming Li, Yuqin Song, Li Zhang, Dengju Li, Huijing Wu, Wei Zhang, Junmin Li, Keshu Zhou, Hui Zhou, Yu Yang, Zhifeng Li, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, IV, Fei Li, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zengjun Li, Shuhua Yi, Hanying Bao, Zusheng Xu, Lugui Qiu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6145.
https://doi.org/10.1182/blood-2023-177820
Published: 2023
Journal Articles

A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial of HH2853 in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-Cell Lymphoma

Free
Huangming Hong, Mingzhi Zhang, Zhigang Peng, Jianzhen Shen, Yuerong Shuang, Hui Zhou, Hongqiang Guo, He Huang, Fei Li, Zhengzi Qian, Lihong Liu, Liang Wang, Wei Yang, Liling Zhang, Pengcheng He, Shen Qian, Fugen Li, Meng Li, Tongyu Lin
Journal: Blood
Blood (2023) 142 (Supplement 1): 304.
https://doi.org/10.1182/blood-2023-180372
Published: 2023
Journal Articles

Time to Lymphoma Treatment within 24 Months in Watchful Waiting Follicular Lymphoma Defines Patients at High Risk for Progression: A Multicenter Analysis

Free
Fenghua Gao, Jing Liu, Jiesong Wang, Lihong Liu, Zhiming Li, Yuqin Song, Xudong Zhang, Hui Zhou, Xiuhua Sun, Wei Zhang, Bing Xu, Liping Su, Wen Shujuan, Rong Tao, Ou Bai, Qingyuan Zhang, Liqun Zou, Xianhuo Wang, Huilai Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4417.
https://doi.org/10.1182/blood-2023-174308
Published: 2023
Journal Articles

Loncastuximab Tesirine Demonstrated Substantial Single-Agent Efficacy and Manageable Safety Profile in Heavily Pretreated Chinese Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Free
Ningjing Lin, Xiuhua Sun, Hui Zhou, Liqun Zou, Keshu Zhou, Lihong Liu, Haiyan Yang, Kai HU, Qingqing Cai, Yao Liu, Jie Jin, Liling Zhang, Wenyu Li, Ye Guo, Wei Yang, Feng Luo, Yanyan Li, Mengqi Zhang, Feinan Lu, Yuqin Song, Jun Zhu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4469.
https://doi.org/10.1182/blood-2023-173645
Published: 2023
Journal Articles

PI3Kδ Inhibitor Linperlisib As a ≥ 3-Line Treatment for Relapsed or Refractory Follicular Lymphoma: A Subgroup Analysis of a Phase II, Single-Arm, Open-Label Trial

Free
Hang Su, Tingyu Wang, Xiuhua Sun, Lihua Qiu, Junning Cao, Zhiming Li, Yuqin Song, Li Zhang, Dengju Li, Huijing Wu, Wei Zhang, Junmin Li, Keshu Zhou, Hui Zhou, Yu Yang, Zhifeng Li, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, IV, Fei Li, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zengjun Li, Shuhua Yi, Hanying Bao, Zusheng Xu, Lugui Qiu
Journal: Blood
Blood (2023) 142 (Supplement 1): 1677.
https://doi.org/10.1182/blood-2023-178710
Published: 2023
Journal Articles

Dose Adjustments of Linperlisib in Relapsed or Refractory Follicular Lymphoma: A Post-Hoc Analysis of a Pivotal Phase II Study

Free
Fangfang Lyu, Junning Cao, Tingyu Wang, Xiuhua Sun, Lihua Qiu, Hang Su, Zhiming Li, Yuqin Song, Li Zhang, Dengju Li, Huijing Wu, Wei Zhang, Junmin Li, Keshu Zhou, Hui Zhou, Yu Yang, Zhifeng Li, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, IV, Fei Li, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zengjun Li, Shuhua Yi, Hanying Bao, Zusheng Xu, Lugui Qiu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6140.
https://doi.org/10.1182/blood-2023-180373
Published: 2023
Journal Articles

Updated Efficacy and Safety Results of Lisaftoclax (APG-2575) in Patients (Pts) with Heavily Pretreated Chronic Lymphocytic Leukemia (CLL): Pooled Analyses of Two Clinical Trials

Free
Keshu Zhou, Mingyuan Sun, Xu Wei, Shuhua Yi, Junyuan Qi, Weiqi Nian, Guohui Cui, Jishi Wang, Xiaoping Zhang, Hong Cen, Fuling Zhou, Jianying Huang, Huilan Liu, Aizong Shen, Liangquan Geng, Ru Feng, Chongyuan Xu, Wenbin Qian, Fei Li, Lihong Liu, Caixia Li, Xielan Zhao, Jie Jin, Hongmei Jing, Dongmei Ji, Fangfang Lyu, Zi Chen, Lichuang Men, Hengbang Wang, Ke Zhang, Liang Xu, Zhang Zhang, Dajun Yang, Jianxiang Wang, Jianyong Li, Yifan Zhai
Journal: Blood
Blood (2023) 142 (Supplement 1): 1900.
https://doi.org/10.1182/blood-2023-183071
Published: 2023